Stockholm, July 6, 2017 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Promore Pharma AB’s shares (short name: PROMO) commenced today on Nasdaq First North in Stockholm. Promore Pharma belongs to the health care sector and is the 69 th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.
Promore Pharma is a biopharmaceutical company specialized in the development of therapeutic peptides for the bioactive wound care market. The company has two therapeutic peptides, PXL01 and LL-37, in late stage clinical phase, and its vision is to provide medical aid for patients with large unmet medical requirements through development of products that enhance and accelerate natural healing processes in the body. Promore Pharma is headquartered at the Karolinska Institutet Science Park in Solna, Sweden. For more information, please visit www.promorepharma.com .
“It is a proud and transforming moment for Promore Pharma,” said Jonas Ekblom, CEO of Promore Pharma. “Our public listing is a natural step for the Company as we enter Phase III clinical studies, the latest stages of the pharmaceutical development chain. I confidently feel that this will bring us closer to our vision of being a category-leading innovation company.”
“We welcome Promore Pharma to Nasdaq First North,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “We are excited to support yet another health care sector company with the increased investor exposure that comes with a Nasdaq First North listing.”
Promore Pharma AB has appointed Redeye AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius .
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
| Media Relations Contact: Erik Granström +46 8 405 78 07 erik.granstrom@nasdaq.com |
